PL198874A1 - Sposob wytwarzania pewnych 2-(4-podstawionych piperazynylo-1)-4-aminochinazolin - Google Patents

Sposob wytwarzania pewnych 2-(4-podstawionych piperazynylo-1)-4-aminochinazolin

Info

Publication number
PL198874A1
PL198874A1 PL19887477A PL19887477A PL198874A1 PL 198874 A1 PL198874 A1 PL 198874A1 PL 19887477 A PL19887477 A PL 19887477A PL 19887477 A PL19887477 A PL 19887477A PL 198874 A1 PL198874 A1 PL 198874A1
Authority
PL
Poland
Prior art keywords
aminochinazolines
making certain
substituted piperazin
piperazin
substituted
Prior art date
Application number
PL19887477A
Other languages
English (en)
Other versions
PL105558B1 (pl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL198874A1 publication Critical patent/PL198874A1/pl
Publication of PL105558B1 publication Critical patent/PL105558B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL1977198874A 1976-06-15 1977-06-15 Sposob wytwarzania 2-/4-podstawionych piperazynylo-1/-4-aminochinazolin PL105558B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69620176A 1976-06-15 1976-06-15

Publications (2)

Publication Number Publication Date
PL198874A1 true PL198874A1 (pl) 1978-04-10
PL105558B1 PL105558B1 (pl) 1979-10-31

Family

ID=24796111

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1977211798A PL111221B1 (en) 1976-06-15 1977-06-15 Preparation of 2-/4-substituted piperazinyl-1/-4-aminoguinazolines
PL1977198874A PL105558B1 (pl) 1976-06-15 1977-06-15 Sposob wytwarzania 2-/4-podstawionych piperazynylo-1/-4-aminochinazolin
PL1977211797A PL113012B1 (en) 1976-06-15 1977-06-15 Method of manufacture of 2/4-substituted piperazinyl-1/-4-aminoquinazolines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1977211798A PL111221B1 (en) 1976-06-15 1977-06-15 Preparation of 2-/4-substituted piperazinyl-1/-4-aminoguinazolines

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1977211797A PL113012B1 (en) 1976-06-15 1977-06-15 Method of manufacture of 2/4-substituted piperazinyl-1/-4-aminoquinazolines

Country Status (34)

Country Link
JP (1) JPS52153985A (pl)
AR (1) AR218251A1 (pl)
AT (1) AT356115B (pl)
BE (1) BE855656A (pl)
BG (3) BG35748A3 (pl)
CA (1) CA1068698A (pl)
CH (3) CH638203A5 (pl)
CS (1) CS202069B2 (pl)
DD (1) DD131021A5 (pl)
DE (1) DE2725019A1 (pl)
DK (1) DK146625C (pl)
EG (1) EG12922A (pl)
ES (1) ES459364A1 (pl)
FI (1) FI66853C (pl)
FR (1) FR2355015A1 (pl)
GB (1) GB1548856A (pl)
GR (1) GR72288B (pl)
HK (1) HK31481A (pl)
HU (1) HU177883B (pl)
IE (1) IE45423B1 (pl)
IL (1) IL52167A (pl)
LU (1) LU77530A1 (pl)
MY (1) MY8100270A (pl)
NL (1) NL172543C (pl)
NO (1) NO147838C (pl)
NZ (1) NZ184168A (pl)
PH (1) PH22196A (pl)
PL (3) PL111221B1 (pl)
PT (1) PT66617B (pl)
RO (3) RO73050A (pl)
SE (2) SE435380B (pl)
SU (2) SU1033002A3 (pl)
YU (1) YU40164B (pl)
ZA (1) ZA773014B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346675A1 (de) * 1983-12-23 1985-07-04 Beiersdorf Ag, 2000 Hamburg Substituierte 1-(4-amino-6,7-dialkoxy-chinazolinyl)-4- cyclohexenyl-derivate des piperazins und homopiperazins, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen und zwischenprodukte
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5654307A (en) * 1994-01-25 1997-08-05 Warner-Lambert Company Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
US5932538A (en) * 1996-02-02 1999-08-03 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3669968A (en) 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines
JPS4966691A (pl) * 1972-10-30 1974-06-27
US3935213A (en) 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
JPS50126682A (pl) * 1974-03-25 1975-10-04

Also Published As

Publication number Publication date
SU1033002A3 (ru) 1983-07-30
CH638516A5 (en) 1983-09-30
DE2725019A1 (de) 1977-12-22
NO147838C (no) 1983-06-22
IE45423B1 (en) 1982-08-25
FI66853B (fi) 1984-08-31
RO77308A (ro) 1981-08-17
DK240877A (da) 1977-12-16
FI771741A (pl) 1977-12-16
EG12922A (en) 1980-03-31
CA1068698A (en) 1979-12-25
CH638203A5 (en) 1983-09-15
SE450120B (sv) 1987-06-09
CH638517A5 (en) 1983-09-30
IL52167A (en) 1981-01-30
PL105558B1 (pl) 1979-10-31
AU2558377A (en) 1978-09-07
AR218251A1 (es) 1980-05-30
BG35748A3 (en) 1984-06-15
JPS5543465B2 (pl) 1980-11-06
NL7705939A (nl) 1977-12-19
NZ184168A (en) 1979-08-31
BG35594A3 (en) 1984-05-15
NO147838B (no) 1983-03-14
BG35747A3 (en) 1984-06-15
LU77530A1 (fr) 1979-03-26
SU946402A3 (ru) 1982-07-23
RO77330A (ro) 1981-06-22
ZA773014B (en) 1978-04-26
DD131021A5 (de) 1978-05-24
ATA386977A (de) 1979-09-15
AT356115B (de) 1980-04-10
HK31481A (en) 1981-07-10
IL52167A0 (en) 1977-07-31
JPS52153985A (en) 1977-12-21
SE8107554L (sv) 1981-12-16
IE45423L (en) 1977-12-15
PL111221B1 (en) 1980-08-30
PT66617A (en) 1977-06-01
CS202069B2 (en) 1980-12-31
DK146625B (da) 1983-11-21
PH22196A (en) 1988-06-28
DK146625C (da) 1984-06-04
HU177883B (en) 1982-01-28
FR2355015A1 (fr) 1978-01-13
PT66617B (en) 1978-10-27
ES459364A1 (es) 1978-03-16
YU40164B (en) 1985-08-31
SE7705745L (sv) 1977-12-16
NL172543C (nl) 1983-09-16
MY8100270A (en) 1981-12-31
FR2355015B1 (pl) 1981-07-24
BE855656A (fr) 1977-12-14
YU132677A (en) 1982-08-31
GB1548856A (en) 1979-07-18
RO73050A (ro) 1981-08-30
NO771919L (no) 1977-12-16
PL113012B1 (en) 1980-11-29
FI66853C (fi) 1984-12-10
SE435380B (sv) 1984-09-24
NL172543B (nl) 1983-04-18
GR72288B (pl) 1983-10-17

Similar Documents

Publication Publication Date Title
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL199603A1 (pl) Sposob wytwarzania nowych pochodnych kwasu pirolokarboksylowego-1
PL215007A1 (pl) Sposob wytwarzania gamma-pironow
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL199298A1 (pl) Sposob wytwarzania 2-bromo-6-fluoro-n-2-imidazolidynylideno-benzaminy
PL196820A1 (pl) Sposob wytwarzania zwiazkow 3-chlorowcometylocefemowych-3
PL198874A1 (pl) Sposob wytwarzania pewnych 2-(4-podstawionych piperazynylo-1)-4-aminochinazolin
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL192578A1 (pl) Sposob wytwarzania nowych n-arylo-n-/1,4-podstawionych piperydynylo/aryloacetamidow
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL199633A1 (pl) Sposob wytwarzania 5-m-toliloksyuracylu
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL202091A1 (pl) Sposob wytwarzania gamma-pyronow
PL197550A1 (pl) Sposob wytwarzania nowych pochodnych fenylopiperazyny
PL201133A1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL196061A1 (pl) Sposob wytwarzania nowych pochodnych indolizyny
PL197646A1 (pl) Sposob wytwarzania pochodnych 1-karbamylouracylu
PL201883A1 (pl) Sposob wytwarzania nowych pochodnych trans-5a-arylo-dziesieciowodorobenzazepiny
PL196543A1 (pl) Sposob wytwarzania nowych pochodnych azyrydyny
PL202697A1 (pl) Sposob wytwarzania 2-bromo-alfa-ergokryptyny